Compare PACB & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACB | ROMA |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Savings Institutions |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 542.0M |
| IPO Year | 2010 | 2022 |
| Metric | PACB | ROMA |
|---|---|---|
| Price | $1.35 | $8.99 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.67 | N/A |
| AVG Volume (30 Days) | ★ 7.0M | 4.5K |
| Earning Date | 05-07-2026 | 12-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.32 | N/A |
| Revenue Next Year | $12.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $1.07 | $1.16 |
| 52 Week High | $2.73 | $11.77 |
| Indicator | PACB | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 50.44 |
| Support Level | $1.27 | $7.56 |
| Resistance Level | $1.47 | $9.75 |
| Average True Range (ATR) | 0.10 | 0.60 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 66.25 | 30.82 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Roma Green Finance Ltd is a professional specialist in the provision of environmental, social and governance (ESG), sustainability and climate change related advisory services through its operating subsidiaries in Hong Kong and Singapore. Its services include Sustainability Program Development, ESG Reporting, Corporate Governance and Risk Management, Climate Change Strategies and Solutions, Environmental Audit, ESG Rating Support and Shareholder Communication, and Education and Training. It operates in one reporting business segment in Hong Kong and Singapore, of which the majority of revenue is derived from Hong Kong.